Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5PPI1

Entry ID Method Resolution Chain Position Source
AF-Q5PPI1-F1 Predicted AlphaFoldDB

No variants for Q5PPI1

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5PPI1

No associated diseases with Q5PPI1

4 regional properties for Q5PPI1

Type Name Position InterPro Accession
domain RNA recognition motif domain 14 - 89 IPR000504-1
domain RNA recognition motif domain 111 - 187 IPR000504-2
domain SRSF9, RNA recognition motif 1 15 - 86 IPR034503
domain SRSF9, RNA recognition motif 2 103 - 186 IPR034995

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.

2 GO annotations of molecular function

Name Definition
protein domain specific binding Binding to a specific domain of a protein.
RNA binding Binding to an RNA molecule or a portion thereof.

5 GO annotations of biological process

Name Definition
alternative mRNA splicing, via spliceosome The process of generating multiple mRNA molecules from a given set of exons by differential use of exons from the primary transcript(s) to form multiple mature mRNAs that vary in their exon composition.
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.
negative regulation of mRNA splicing, via spliceosome Any process that stops, prevents or reduces the rate or extent of mRNA splicing via a spliceosomal mechanism.
response to alkaloid Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
response to toxic substance Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q13242 SRSF9 Serine/arginine-rich splicing factor 9 Homo sapiens (Human) PR
Q9D0B0 Srsf9 Serine/arginine-rich splicing factor 9 Mus musculus (Mouse) PR
10 20 30 40 50 60
MSGWADERGG EGDGRIYVGN LPTDVREKDL EDLFYKYGRI REIELKNRHG LVPFAFVRFE
70 80 90 100 110 120
DPRDAEDAIY GRNGYDYGQC RLRVEFPRAY GGRGGWPRAS RNGPPTRRSD FRVLVSGLPP
130 140 150 160 170 180
SGSWQDLKDH MREAGDVCYA DVQKDGMGMV EYLRKEDMEY ALRKLDDTKF RSHEGETSYI
190 200 210 220
RVYPERGTSY GCSRSRSGSR GRDSPYQSRG SPHYFSPFRP Y